Editor-in-chief James Mawson takes an in-depth look at what the Horizon Europe budget needs to achieve.

Editor-in-chief James Mawson takes a look at assumed problems around university IP and considers the opportunities of university venture funds ahead of a report by Hermann Hauser.

Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

A report released last week by the Center for Advancing Innovation and PatSnap shows the US and the EU are falling behind on the number of patents filed.

July - August issue editorial by Thierry Heles, editor

PraxisAuril's spring conference continues to go from strength to strength, with one in three delegates a first-time attendant.

June issue editorial by GUV editor Thierry Heles.